小鱼儿
Lv5
1370 积分
2022-03-29 加入
-
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
6个月前
已完结
-
Effects and risk factors of TAS-102 in real-worldpatients with metastatic colorectal cancer, EROTASR study
6个月前
已完结
-
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
10个月前
已完结
-
Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study
1年前
已完结
-
Analysis of neutropenia as a predictive factor of the efficacy of trifluridine-tipiracil treatment
1年前
已关闭
-
Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990-2019
1年前
已完结
-
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
1年前
已完结
-
Combination Therapy, Including Bevacizumab, for Advanced Colorectal Cancer
1年前
已完结
-
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
1年前
已完结
-
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study
1年前
已完结